ATE55123T1 - Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel. - Google Patents

Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.

Info

Publication number
ATE55123T1
ATE55123T1 AT86402210T AT86402210T ATE55123T1 AT E55123 T1 ATE55123 T1 AT E55123T1 AT 86402210 T AT86402210 T AT 86402210T AT 86402210 T AT86402210 T AT 86402210T AT E55123 T1 ATE55123 T1 AT E55123T1
Authority
AT
Austria
Prior art keywords
pyridinalkylamines
production
medicinal products
image
carbon atoms
Prior art date
Application number
AT86402210T
Other languages
English (en)
Inventor
Claude Laruelle
Marcel Lepant
Bernard Raynier
Original Assignee
Panmedica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica Sa filed Critical Panmedica Sa
Application granted granted Critical
Publication of ATE55123T1 publication Critical patent/ATE55123T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT86402210T 1985-10-11 1986-10-06 Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel. ATE55123T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MA20776A MA20552A1 (fr) 1985-10-11 1985-10-11 Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations
EP86402210A EP0223647B1 (de) 1985-10-11 1986-10-06 Alkylcarbonsäureamide von Pyridinalkylaminen, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE55123T1 true ATE55123T1 (de) 1990-08-15

Family

ID=32292295

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86402210T ATE55123T1 (de) 1985-10-11 1986-10-06 Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.

Country Status (13)

Country Link
US (1) US4794121A (de)
EP (1) EP0223647B1 (de)
JP (1) JPS63270663A (de)
KR (1) KR870003987A (de)
AT (1) ATE55123T1 (de)
AU (1) AU600676B2 (de)
CA (1) CA1282413C (de)
DE (1) DE3673129D1 (de)
ES (1) ES2016931B3 (de)
FR (1) FR2591591B1 (de)
GR (1) GR3000969T3 (de)
MA (1) MA20552A1 (de)
ZA (1) ZA867397B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797411A (en) * 1986-07-18 1989-01-10 Farmitalia Carlo Erba S.P.A. Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
DE3856493T2 (de) * 1987-08-01 2002-05-23 Takeda Chemical Industries, Ltd. Alpha-ungesättigte Amine, ihre Herstellung und Verwendung
US7276555B2 (en) * 2002-05-21 2007-10-02 Hexion Specialty Chemicals, Inc. Amide-modified resin or hydrocarbyl moiety for dispersing a pigment
WO2025252600A1 (en) * 2024-06-04 2025-12-11 Angelini Pharma S.P.A. Activating compounds of potassium channels kv7.2/kv7.3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES420074A1 (es) * 1973-10-30 1976-07-01 Made Labor Sa Un metodo para la produccion industrial de dipropilacetami-das n-sustituidas.
ES479959A1 (es) * 1979-04-26 1979-12-01 Made Labor Sa Un procedimiento para la produccion industrial de 1,2-diaci-lamino-1,2-di(4-piridil)etanos.
US4452983A (en) * 1981-06-08 1984-06-05 Riker Laboratories, Inc. Phenolic derivative
IL69392A (en) * 1982-08-13 1987-01-30 Sanofi Sa N-oxide nicotinamide derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES2016931B3 (es) 1990-12-16
GR3000969T3 (en) 1991-12-10
ZA867397B (en) 1987-05-27
KR870003987A (ko) 1987-05-06
FR2591591A1 (fr) 1987-06-19
JPS63270663A (ja) 1988-11-08
AU600676B2 (en) 1990-08-23
DE3673129D1 (de) 1990-09-06
AU6306886A (en) 1987-04-16
CA1282413C (en) 1991-04-02
FR2591591B1 (fr) 1988-11-18
MA20552A1 (fr) 1986-07-01
US4794121A (en) 1988-12-27
EP0223647A2 (de) 1987-05-27
EP0223647A3 (en) 1987-09-30
EP0223647B1 (de) 1990-08-01

Similar Documents

Publication Publication Date Title
DE3762412D1 (de) (meth)acrylsaeureester und ihre verwendung zur herstellung von dentalmassen.
NO901392L (no) Immunomodulerende azaspiraner.
NO933200L (no) Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE3670081D1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
EP0254902A3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
ATE174026T1 (de) Chromen-derivate mit einer trien-kette zur verwendung bei der behandlung der osteoporose und der entzündlichen erkrankungen
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
FI881609A0 (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE121405T1 (de) Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE21101T1 (de) N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel.
ATE44961T1 (de) Substituierte o-sulfonyl-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE169289T1 (de) Imido-percarbonsäuren
DK74189A (da) Laegemiddel til behandling af mavesaar
DE3780191D1 (de) Octahydroindolizine analgesica und 7-keto-zwischenprodukte.
DK7286D0 (da) Octahydroindoliziner
ATE162195T1 (de) 4-hydroxy-phenyl-beta-d-glukose-monoester, verfahren zur ihrer herstellung und ihre verwendung in der kosmetik, der pharmazie, als zahnpflegemitteln und lebensmitteln
SE8601733L (sv) 1-hydroxi-8-acyloxi-10-acyl-antroner, sett att framstella dessa och deras anvendning human- och veterinermedicin och i kosmetika
DE3676378D1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ATE70050T1 (de) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten.
DE3862083D1 (de) Salze von 6-piperidino-2,4-diaminopyrimidin-3-oxyd und von derivaten der thiamorpholin-3-on-5-carbonsaeure und deren verwendung in kosmetischen stoffen und als heilmittel.
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
SE7903233L (sv) Bensylidenestrar
SE8200745L (sv) Nya derivat av 1,8-dihydroxi-9-antron-serien, substituerade i 10-stellningen med en omettad grupp och anvendning derav inom human- eller veterinermedicinen och inom kosmetiken

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee